Page 137 - NobleCon20-Book-Project

P3 Health Partners Inc.

SELECTED FINANCIAL ITEMS PIII

(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 346.86 388.49 379.16 362.12 1,476.63
Gross Profit (20.82) 6.43 13.99 (39.80) (40.20)
Gross Margin -6% 2% 4% -11% -3%
EBIT (64.26) (43.83) (31.33) (106.99) (246.42)
EBIT Margin -19% -11% -8% -30% -17%
Net Income to Common Shareholders (69.11) (49.61) (28.77) (102.85) (250.34)
Net Margin -20% -13% -8% -28% -17%

Balance Sheet Key Items
Total Assets 860.97 855.93 892.76 833.33 833.33
Cash & Short Term Investments 36.32 27.30 73.09 62.96 62.96
% of Assets 4% 3% 8% 8% 8%
Current Assets -Total 166.02 182.96 242.10 215.07 215.07
% of Assets 19% 21% 27% 26% 26%
Total Liabilities 427.31 470.49 527.93 569.42 569.42
% of Assets 50% 55% 59% 68% 68%
Current Liabilities - Total 299.37 333.65 352.25 405.32 405.32
% of Assets 35% 39% 39% 49% 49%
Long Term Debt 108.32 118.12 133.12 133.23 133.23
% of Assets 13% 14% 15% 16% 16%
Total Equity 433.66 385.43 364.83 263.91 263.91
% of Assets 50% 45% 41% 32% 32%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (15.88) (20.03) (10.24) (22.62) (68.77)
Net Cash Flow - Investing 0.21 NA NA 15.00 15.21
Net Cash Flow - Financing (0.84) 11.40 56.14 (2.49) 64.21

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference